BANK OF AMERICA CORP /DE/ - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 79 filers reported holding HUMACYTE INC in Q2 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$156,972
+353.3%
53,574
+342.5%
0.00%
Q2 2023$34,626
-68.3%
12,107
-65.7%
0.00%
Q1 2023$109,136
-54.4%
35,319
-68.8%
0.00%
Q4 2022$239,177
+61.6%
113,354
+149.5%
0.00%
Q3 2022$148,000
-37.3%
45,427
-38.3%
0.00%
Q2 2022$236,000
+39.6%
73,666
+208.2%
0.00%
Q1 2022$169,000
+231.4%
23,904
+247.1%
0.00%
Q4 2021$51,000
+27.5%
6,887
+96.7%
0.00%
Q3 2021$40,0003,5020.00%
Other shareholders
HUMACYTE INC shareholders Q2 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders